Literature DB >> 11498774

Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype.

S Krueger1, U Kellner, F Buehling, A Roessner.   

Abstract

Alterations in cathepsin L expression and trafficking have been associated with the progression and metastasis of several tumor entities. In the present study, we examined the effects of various cathepsin L antisense (as) phosphorothioate oligonucleotides on both the expression of cathepsin L and the invasive potential of the human osteosarcoma cell line MNNG/HOS. Seven oligonucleotides of 20-bp length each and one random control oligonucleotide were chosen to block cathepsin L expression. Northern blot analysis demonstrated a significant reduction in cathepsin L mRNA expression by the six antisense oligonucleotides at a concentration of 10 microM. Cathepsin L protein expression was reduced significantly (50-85%) by the antisense oligonucleotides, as compared with the controls. Adhesion to matrices of collagen I and matrigel was not affected. In in vitro motility and invasion assays performed in uncoated and precoated transwell chambers, the ability of cells to migrate through the filters was inhibited by 35-75% using antisense oligonucleotides. The random control did not show any inhibitory effect. These data demonstrate that in MNNG/HOS cells cathepsin L influences cellular malignancy by promoting migration and basement membrane degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498774     DOI: 10.1038/sj.cgt.7700341

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  14 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

2.  Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease.

Authors:  Thomas Kalinski; Sabine Krueger; Antje-Friederike Pelz; Peter Wieacker; Roland Hartig; Martin Röpke; Regine Schneider-Stock; Frank Dombrowski; Albert Roessner
Journal:  Virchows Arch       Date:  2005-02-25       Impact factor: 4.064

3.  Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Authors:  Sabine Hombach-Klonisch; Joanna Bialek; Bogusz Trojanowicz; Ekkehard Weber; Hans-Jürgen Holzhausen; Josh D Silvertown; Alastair J Summerlee; Henning Dralle; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathways.

Authors:  Lorena Urbanelli; Francesco Trivelli; Luisa Ercolani; Eleonora Sementino; Alessandro Magini; Brunella Tancini; Raffaella Franceschini; Carla Emiliani
Journal:  Mol Cell Biochem       Date:  2010-06-04       Impact factor: 3.396

5.  Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.

Authors:  J Chen; C Röcken; J Hoffmann; S Krüger; U Lendeckel; A Rocco; S Pastorekova; P Malfertheiner; M P A Ebert
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

6.  Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.

Authors:  Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Elisabet Cuyàs; Bruna Corominas-Faja; Esther Rodríguez-Gallego; Salvador Fernández-Arroyo; Begoña Martin-Castillo; Jorge Joven; Javier A Menendez
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

7.  The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.

Authors:  Aleksandra Glogowska; Janette Pyka; Astrid Kehlen; Marek Los; Paul Perumal; Ekkehard Weber; Sheue-yann Cheng; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Authors:  Qinglian Tang; Jinchang Lu; Changye Zou; Yang Shao; Yan Chen; Swami Narala; Hui Fang; Huaiyuan Xu; Jin Wang; Jingnan Shen; Rama Khokha
Journal:  Oncogene       Date:  2018-04-03       Impact factor: 9.867

9.  Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.

Authors:  S M Pulukuri; B Gorantla; J A Knost; J S Rao
Journal:  Oncogene       Date:  2009-06-08       Impact factor: 9.867

10.  The importance of cysteine cathepsin proteases for placental development.

Authors:  Aikaterini Varanou; Sarah L Withington; Lorin Lakasing; Catherine Williamson; Graham J Burton; Myriam Hemberger
Journal:  J Mol Med (Berl)       Date:  2006-01-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.